1,898 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Acquired by GAMMA Investing LLC

GAMMA Investing LLC bought a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 1,898 shares of the company’s stock, valued at approximately $28,000.

Other hedge funds have also recently bought and sold shares of the company. Lindbrook Capital LLC raised its holdings in Takeda Pharmaceutical by 40.6% during the 4th quarter. Lindbrook Capital LLC now owns 4,065 shares of the company’s stock worth $58,000 after buying an additional 1,174 shares during the period. Blue Trust Inc. raised its holdings in Takeda Pharmaceutical by 91.1% during the 4th quarter. Blue Trust Inc. now owns 5,837 shares of the company’s stock worth $91,000 after buying an additional 2,782 shares during the period. Allworth Financial LP raised its holdings in Takeda Pharmaceutical by 111.2% during the 3rd quarter. Allworth Financial LP now owns 6,183 shares of the company’s stock worth $96,000 after buying an additional 3,256 shares during the period. Larson Financial Group LLC acquired a new stake in Takeda Pharmaceutical during the 4th quarter worth approximately $116,000. Finally, Bruce G. Allen Investments LLC acquired a new stake in Takeda Pharmaceutical during the 4th quarter worth approximately $138,000. 9.17% of the stock is currently owned by institutional investors and hedge funds.

Takeda Pharmaceutical Stock Performance

Shares of TAK stock opened at $13.36 on Tuesday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.55 and a current ratio of 1.06. The company has a market capitalization of $42.28 billion, a P/E ratio of 20.24, a price-to-earnings-growth ratio of 3.05 and a beta of 0.56. The company’s 50 day moving average price is $13.88 and its two-hundred day moving average price is $14.11. Takeda Pharmaceutical Company Limited has a 52 week low of $13.01 and a 52 week high of $17.11.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.